JCPenney Gets $2.25...
Health Care: Drugs
Cytori Therapeutics Inc. (CYTX: NASDAQ)
$2.52 -0.05 | -1.95%
05/24/13 - 09:30 AM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 14.50M | 7.98M | 10.63M | 14.73M |
| Cost of Sales | 2.14M | 2.27M | 2.27M | 1.00M |
| Gross Operating Profit | 12.36M | 5.71M | 8.35M | 13.73M |
| Selling, General, and Administrative Expenses | 25.16M | 28.29M | 23.61M | 17.00M |
| Research & Development | 13.63M | 10.90M | 9.69M | 12.23M |
| Operating Income before D & A (EBITDA) | -26.42M | -33.48M | -24.94M | -15.50M |
| Depreciation & Amortization | 1.86M | 1.57M | 1.63M | 2.39M |
| Interest Income | 4.00K | 9.00K | 9.00K | 20.00K |
| Other Income - Net | -314.00K | 1.22M | 1.28M | -3.87M |
| Special Income / Charges | -131.00K | 4.36M | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -28.89M | -29.67M | -25.44M | -21.79M |
| Interest Expense | 3.39M | 2.78M | 2.05M | 1.43M |
| Pre-Tax Income | -32.28M | -32.45M | -27.49M | -23.22M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -32.28M | 0.00 | 0.00 | 0.00 |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -32.28M | 0.00 | 0.00 | 0.00 |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -32.28M | -32.45M | -27.49M | -23.22M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-32.15M | -4.36M | 0.00 | 0.00 |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -32.28M | 0.00 | 0.00 | 0.00 |
| Basic EPS from Continuing Ops. | -0.55 | -0.61 | -0.60 | -0.65 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.55 | -0.61 | -0.60 | -0.65 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.55 | -0.61 | -0.60 | -0.65 |
| Basic Normalized Net Income/Share | -0.55 | n.a. | n.a. | n.a. |
| EPS fr Continuing Ops. | -0.55 | -0.61 | -0.60 | -0.65 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.55 | -0.61 | -0.60 | -0.65 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.55 | -0.61 | -0.60 | -0.65 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.55 | n.a. | n.a. | n.a. |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with CYTX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- UserMy SP portfolio
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor6 Drug Stocks Unworthy of B...
Latest CYTX Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.16.13 | 03:04 pm
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- Stocks Socked Despite Upbeat China Numbers; Apple Falls 12.14.12 | 04:12 pm
- 5 Stocks Under $10 Set to Soar 10.11.12 | 01:10 pm
- 5 Biotech Stocks Under $10 Blasting Higher 08.14.12 | 03:08 pm
- 5 Biotech Stocks Under $5 Making Bullish Moves 06.21.12 | 01:06 pm
- 8 Stocks Under $10 Soaring Higher 05.10.12 | 01:05 pm
- Tuesday's Top 10 Articles, Videos on TheStreet 02.07.12 | 01:02 pm
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- 8 Stocks Under $10 Ripping Higher 01.26.12 | 02:01 pm
Press Releases for CYTX
- Cytori Patents Method Of Treating Renal Diseases Using Adipose-Derived Regenerative Cells - Business Wire 03.28.13 | 08:03 am
- Cytori Provides Update In 510(k) Appeal Decision - Business Wire 03.22.13 | 02:03 pm
- Cytori Therapeutics To Present At The 25th Annual Roth Conference On March 18 - Business Wire 03.11.13 | 08:03 am
- Cytori Reports 2012 Business And Financial Results; Provides Outlook For 2013 - Business Wire 03.07.13 | 04:03 pm
- Cytori To Webcast Fourth Quarter And Year End Financial Results On March 7 - Business Wire 02.28.13 | 08:02 am
- Cytori Appoints Dr. Steven Kesten As Executive Vice President And Chief Medical Officer - Business Wire 02.26.13 | 08:02 am
- Intravase® Approval Opens Vascular Market For Cytori - Business Wire 02.25.13 | 09:02 am
- Cytori Announces Presentation At Biotech Showcase™ On January 8th - Business Wire 01.04.13 | 08:01 am
- Cytori Therapeutics Prices $20.0 Million Public Offering Of Common Stock - Business Wire 12.14.12 | 09:12 am
- Cytori Therapeutics Proposes Public Offering Of Common Stock - Business Wire 12.13.12 | 04:12 pm
Partner Headlines for CYTX
- With Cytori Therapeutics, The Waiting Is The Hardest Part - Seeking Alpha 08.14.12 | 09:08 am
- Cytori Is A Compelling Short Sale Opportunity - Seeking Alpha 03.19.12 | 09:03 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 07.13.11 | 09:07 am
- Cytori Therapeutics: Sales Miss? Yes. Bad Quarter? No - Seeking Alpha 05.06.11 | 03:05 pm
- Some Hidden Gem Stocks That May Have High Returns! - AOL 04.05.11 | 07:04 pm
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- 9 Cheap Stocks Under $10 Making New Price Highs - Seeking Alpha 03.25.11 | 08:03 am
- Options Brief: Cytori Therapeutics (CYTX) - Benzinga 03.17.11 | 01:03 pm
